These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 37289211)

  • 1. Pulmonary hypertension associated with left heart disease.
    Wissmüller M; Dohr J; Adler J; Ochs L; Tichelbäcker T; Hohmann C; Baldus S; Rosenkranz S
    Herz; 2023 Aug; 48(4):266-273. PubMed ID: 37289211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pulmonary hypertension associated with left heart disease (group 2)].
    Wissmüller M; Tichelbäcker T; Finke K; Dohr J; Adler J; Ochs L; Hohmann C; Baldus S; Rosenkranz S
    Dtsch Med Wochenschr; 2023 Nov; 148(23):1498-1506. PubMed ID: 37949078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary hypertension associated with left-sided heart failure.
    Adler J; Gerhardt F; Wissmüller M; Adler C; Baldus S; Rosenkranz S
    Curr Opin Cardiol; 2020 Nov; 35(6):610-619. PubMed ID: 32969856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: Role of the pre-capillary component.
    Caravita S; Faini A; Carolino D'Araujo S; Dewachter C; Chomette L; Bondue A; Naeije R; Parati G; Vachiéry JL
    PLoS One; 2018; 13(6):e0199164. PubMed ID: 29920539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular heart failure and pulmonary hypertension.
    Rosenkranz S; Gibbs JS; Wachter R; De Marco T; Vonk-Noordegraaf A; Vachiéry JL
    Eur Heart J; 2016 Mar; 37(12):942-54. PubMed ID: 26508169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary vascular disease in pulmonary hypertension due to left heart disease: pathophysiologic implications.
    Omote K; Sorimachi H; Obokata M; Reddy YNV; Verbrugge FH; Omar M; DuBrock HM; Redfield MM; Borlaug BA
    Eur Heart J; 2022 Sep; 43(36):3417-3431. PubMed ID: 35796488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary Hypertension Due to Left Heart Disease: Diagnosis, Pathophysiology, and Therapy.
    Al-Omary MS; Sugito S; Boyle AJ; Sverdlov AL; Collins NJ
    Hypertension; 2020 Jun; 75(6):1397-1408. PubMed ID: 32336230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pulmonary hypertension associated with left heart disease (group 2)].
    Schmidt KH; Bikou O; Blindt R; Bruch L; Felgendreher R; Hohenforst-Schmidt W; Holt S; Ladage D; Pfeuffer-Jovic E; Rieth A; Schmeisser A; Schnitzler K; Stadler S; Steringer-Mascherbauer R; Yogeswaran A; Kuebler WM
    Pneumologie; 2023 Nov; 77(11):926-936. PubMed ID: 37963482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary Hypertension Due to Left Heart Disease-A Practical Approach to Diagnosis and Management.
    Lee F; Mielniczuk LM
    Can J Cardiol; 2021 Apr; 37(4):572-584. PubMed ID: 33217522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary hypertension associated with left heart disease: Updated Recommendations of the Cologne Consensus Conference 2018.
    Rosenkranz S; Lang IM; Blindt R; Bonderman D; Bruch L; Diller GP; Felgendreher R; Gerges C; Hohenforst-Schmidt W; Holt S; Jung C; Kindermann I; Kramer T; Kübler WM; Mitrovic V; Riedel A; Rieth A; Schmeisser A; Wachter R; Weil J; Opitz CF
    Int J Cardiol; 2018 Dec; 272S():53-62. PubMed ID: 30527996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical-imaging-pathological correlation in pulmonary hypertension associated with left heart disease.
    van de Veerdonk MC; Roosma L; Trip P; Gopalan D; Vonk Noordegraaf A; Dorfmüller P; Nossent EJ
    Eur Respir Rev; 2024 Jan; 33(171):. PubMed ID: 38417969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Considerations in the Diagnosis and Management of Pulmonary Hypertension Associated With Left Heart Disease.
    Ilonze OJ; Ebong IA; Guglin M; Nair A; Rich J; McLaughlin V; Tedford RJ; Mazimba S
    JACC Heart Fail; 2024 Aug; 12(8):1328-1342. PubMed ID: 38970588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updates in the Pharmacotherapy of Pulmonary Hypertension in Patients with Heart Failure with Preserved Ejection Fraction.
    Segovia F; Garcia H; Alkhateeb H; Mukherjee D; Nickel N
    Cardiovasc Hematol Disord Drug Targets; 2023; 23(4):215-225. PubMed ID: 37921162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of the Use of Pulmonary Arterial Hypertension Pharmacotherapy in Patients with Pulmonary Hypertension Secondary to Left Heart Disease: A Systematic Review.
    Kido K; Coons JC
    Pharmacotherapy; 2019 Sep; 39(9):929-945. PubMed ID: 31349390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update in approaches to pulmonary hypertension because of left heart disease.
    Kennedy JLW; Mihalek AD
    Curr Opin Pulm Med; 2022 Sep; 28(5):337-342. PubMed ID: 35838362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary hypertension associated with left heart disease: characteristics, emerging concepts, and treatment strategies.
    Haddad F; Kudelko K; Mercier O; Vrtovec B; Zamanian RT; de Jesus Perez V
    Prog Cardiovasc Dis; 2011; 54(2):154-67. PubMed ID: 21875514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrected MRI Pulmonary Transit Time for Identification of Combined Precapillary and Postcapillary Pulmonary Hypertension in Patients With Left Heart Disease.
    Gong C; Guo X; Wan K; Chen C; Chen X; Guo J; He J; Yin L; Wen B; Pu S; Chen Y
    J Magn Reson Imaging; 2023 May; 57(5):1518-1528. PubMed ID: 37021578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease.
    Huston JH; Shah SJ
    Circ Res; 2022 Apr; 130(9):1382-1403. PubMed ID: 35482841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future of group 2 pulmonary hypertension: Exploring clinical trials and therapeutic targets.
    Awada C; Boucherat O; Provencher S; Bonnet S; Potus F
    Vascul Pharmacol; 2023 Aug; 151():107180. PubMed ID: 37178949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [2022 ESC/ERS guidelines on the diagnostics and treatment of pulmonary hypertension : A focussed review].
    Rosenkranz S
    Herz; 2023 Feb; 48(1):23-30. PubMed ID: 36648489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.